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Genome-wide association analysis on monozygotic twin-pairs offers a route to discovery of gene–
environment interactions through testing for variability loci associated with sensitivity to individual environ-
ment/lifestyle. We present a genome-wide scan of loci associated with intra-pair differences in serum lipid
and apolipoprotein levels. We report data for 1,720 monozygotic female twin-pairs from GenomEUtwin
project with 2.5 million SNPs, imputed or genotyped, andmeasured serum lipid fractions for both twins. We
found one locus associated with intra-pair differences in high-density lipoprotein cholesterol, rs2483058
in an intron of SRGAP2, where twins carrying the C allele are more sensitive to environmental factors
(P=3.98× 10−8). We followed up the association in further genotyped monozygotic twins (N=1,261),
which showed a moderate association for the variant (P=0.200, same direction of an effect). In addition,
we report a new association on the level of apolipoprotein A-II (P=4.03× 10−8).
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Serum lipid levels have been associated with cardiovascular
diseases, metabolic syndrome, and type II diabetes (Kan-
nel et al., 1961; Miller & Miller, 1975; Pilia et al., 2006).
Variation in lipids levels is highly influenced by herita-
ble factors (Friedlander et al., 1997), and 95 loci have al-
readybeenassociatedwith levels of high-density lipoprotein
(HDL) cholesterol, low-density lipoprotein (LDL) choles-
terol, triglycerides (TG), and total cholesterol (TC) in nu-
merous study samples and replicated in various populations
using genome-wide approaches (Aulchenko et al., 2008;
Kathiresan et al., 2008; Kooner et al., 2008; Teslovich et al.,
2010; Willer et al., 2008). However, the genetic associations
affecting blood apolipoproteins have been studied mainly
with the candidate gene approach.
Data emerging from epidemiological studies imply that
genes interact with environmental factors causing addi-
tional variability in lipid levels (Thorn et al., 1998; Viss-
cher & Duffy, 2006). In animal and plant models, G ×
E interactions can be studied by controlling the environ-
mental factors. In human populations, the environment
of an individual is highly variable and the individual can
choose environments. This makes it difficult to find loci
interacting with specified environmental factors. Recently
published screen for G × E interactions identified a lo-
cus where, depending on the genotype at that locus, the
connection between waist-to-hip ratio and total cholesterol
differed (Surakka et al., 2011), but to detect the association,
over 40,000 individuals from various population cohorts
were used.
The total environmental sensitivity of a locus, without
specifying which environmental factors are salient, can be
tested in general population samples by comparing the trait
variances between different genotype classes in genome-
wide association (GWA) studies. For this sensitivity asso-
ciation screening, monozygotic (MZ) twins offer the addi-
tional benefit of controlling for possible confounding due
to possible epistatic effects. MZ twin-pairs share essentially
identical genomes at the sequence level and the differences
within pairs; for example, lipid levels reflect environmen-
tally influenced differences. Genetic variation may deter-
mine the extent to which environmental differences lead to
phenotypic within pair variability (Magnus et al., 1981). An
association with within-MZ-pair trait differences directly
indicates gene–environment interaction, where one allele
increases or restricts the effect of environmental factors or
environmental factors affect the gene expression differently
for different alleles. This is seen as elevated or diminished
levels of variability in trait values. In a recent methodolog-
ical paper, the power to detect variability association using
either difference between twins or variability in population
approaches was evaluated (Visscher & Posthuma, 2010).
The study showed that using MZ twins is more powerful
than the approach using population variances, when the
trait under examination has high within-pair correlations
in MZ twin-pairs.
In this study we have screened for genetic “variability”
loci where the loci are associated with differences in lipid
levels between the two members of a pair in our GWA
study in MZ female twins. More specifically, the aim of our
study was to search variability genes forHDL, LDL, TC, TG,
and apolipoprotein A-I, A-II, B, and E (APOA1, APOA2,
APOB, andAPOE respectively). For the apolipoprotein data
at hand we have additionally screened for apolipoprotein
level associations.
Materials and Methods
Study Samples
The Danish, Dutch, Finnish, Italian, Norwegian, and
Swedish national twin cohorts, together with St Thomas’
twin cohort in the United Kingdom and an Australian
twin cohort, form the basis of the GenomEUtwin project
(www.genomeutwin.org), a collection of 800,000 twins
(Peltonen & GenomEUtwin, 2003). From these cohorts,
female MZ pairs, aged 20–80 years, with blood lipid mea-
surements available on both members were selected, and
the sample consisted of pairs from Australia (459 pairs),
Denmark (173 pairs), Finland (152 pairs), the Netherlands
(331 pairs), Sweden (301 pairs), and the United Kingdom
(462 pairs). DNA samples from one member of each pair
were used for genotyping.
Verification of Zygosity
To verify the zygosity andmonitor for possible sample mix-
ups, a subset of the samples were subjected to genotyping
of microsatellite or single nucleotide polymorphism (SNP)
panels prior to the genome-wide analysis. The zygosity
of all twin-pairs from the United Kingdom and Finland
was verified by genotyping both twins of each twin-pair
against a marker panel assaying of nine polymorphic au-
tosomal (AC00818, D1S425, D2S338, D10S1651, D13S263,
D16S539, D18S1102, D20S448, and GDB371492) and one
X-linked microsatellite loci (DXS1227) in addition to the
amelogenin locus yielding X- and Y-chromosomal-specific
bands. The zygosity of the Danish samples was primarily
assessed by nine DNA-based microsatellite markers with
the PE Applied Biosystems AmpFISTR Profiler Plus Kit.
For 10 twin-pairs, the zygosity was verified using the same
microsatellite panel as described above. The zygosity of
the Australian twin-pairs was verified using a commercial
kit (AmpF1STR Profiler Plus Amplification KIT, Applied
Biosystems, Foster City, CA) that analyzed nine indepen-
dent, highly polymorphic DNA markers, plus the amel-
ogenin marker for sex (Nyholt, 2006). The zygosity of the
Swedish twin-pairswas verified by genotyping of a validated
panel of 47 SNPs as described in Hannelius et al. (2007).
Genotyping and Quality Control
The samples were genotyped using the Infinium II as-
say (Steemers et al., 2006) on the HumanHap300-Duo
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Genotyping BeadChips (Illumina Inc, San Diego, USA).
Genotyping was performed according to the manufactur-
ers’ instructions (Infinium II Assay Two-Sample Manual,
#11230506 rev. A, Illumina Inc.). In total, 318,237 SNPs
were genotyped on the BeadChips. The signal intensity
data were converted into genotypes using the Illumina
Beadstudio 2.0 software. Genotypes were assigned using
custom-defined cluster positions generated from samples
genotyped in-house. A total of 1,922 subjects were geno-
typed, of which two-thirds were processed and genotyped
at the Finnish Genome Center in Helsinki and one-third
at the SNP Technology Platform, Uppsala University, Upp-
sala, Sweden (www.genotyping.se).Toverify the consistency
of genotyping between laboratories, 14 duplicate samples
were genotyped at both sites. The generated ∼4.4 million
genotypes were compared for consistency, yielding a re-
producibility rate of 99.99%. The quality of samples and
reagents was monitored by sample call rates, sample het-
erozygosity rates, and sex. Twenty-eight samples yielding
<95% SNP call rates were discarded. Altogether, successful
genotyping was performed on 1,868 unrelated subjects, of
which 93.5% had a call rate of >99%. The average sample
heterozygosity rate varied between 30.9% and 39.1%.
Imputation
Before imputation, individuals of non-European ori-
gin and with genotyping frequency of lower than
95% were excluded. These resulted in 1,720 indi-
viduals (Australia= 421, Denmark= 168, Finland= 137,
the Netherlands= 275, Sweden= 297, and the United
Kingdom= 422) in the final analysis set. SNPs having
minor allele frequency of lower than 1%, Hardy Wein-
berg Equillibrium Fisher’s exact test P value of lower than
1× 10−6, or call rate lower than 99% were removed. The
imputation was done using IMPUTE v2.0 (Howie et al.,
2009) with reference haplotypes of HapMap 2 release
22 (http://hapmap.ncbi.nlm.nih.gov/downloads/phasing/
2007-08˙rel22/phased/).
Lipid Measurements
In all twin cohorts, we measured HDL, LDL, TC, and TG
according to standard enzymatic methods. For a subset of
twin-pairs, we also measured apolipoproteins A-I, A-II, B,
and E, using immunoassays as described in Beekman et al.
(2002).
Statistical Analysis
Because of a skewed distribution, TG and apolipoprotein
A1, A2, B, and E values were log-transformed and, for all
of phenotypes, outliers deviating more than three times the
standard deviation from the traitmeanwere removed. Then
means and absolute differences in lipid and apolipoprotein
values were calculated for each pair. Both intra-pair dif-
ferences and means were transformed into inverse normal
distribution by rank for further analysis. Trait values were
then adjusted for age (and differences additionally by mean
effect) using a linear regressionmodel. Association analyses
between the imputed SNP probabilities and adjusted differ-
ences and means were conducted using SNPtest (Marchini
et al., 2007). Cohort-specific results were then combined
using the inverse variance meta-analysis method func-
tion inMetABEL (http://mga.bionet.nsc.ru/∼yurii/ABEL/)
package for statistical analysis program, R (http://cran.r-
project.org/). We applied minor allele frequency threshold
of 5% and imputation quality threshold of proper info>0.4
before meta-analysis.
Replication Samples
The Finnish replication twin set is a part of the Nico-
tine Addiction Genetics – Finland (FTC/NAG-FIN) study.
FTC/NAG-FIN sample was ascertained from the Finnish
Twin Cohort study consisting of adult twins born between
1938 and 1957 (www.twinstudy.helsinki.fi). Based on ear-
lier health questionnaires, the twin-pairs concordant for
ever-smoking were identified and recruited alongwith their
family members (mainly siblings) for the NAG-FIN study
(N= 2,265) as part of the consortium, including Finland,
Australia, and United States (Broms et al., 2012; Loukola
et al., 2008). Data collection took place between 2001 and
2005. The dataset was genotyped with Illumina human
670K chip in Wellcome Trust Sanger Institute.
The additional Swedish twins were from the TwinGene
project, which is a part of the Swedish Twin registry. Twins
born before 1958 were contacted to participate in a simple
health check-up, withmeasurement of height, weight, waist
and hip circumference, and blood pressure. Health and
medication data were collected from self-reported ques-
tionnaires, and blood sampling materials were mailed to
the subjects who then went to a local healthcare center for
blood sampling for subsequent DNA extraction, serum col-
lection, and clinical chemistry tests. Dataset was genotyped
at the SNP Technology Platform in Uppsala University with
Illumina OmniExpress 700K chip.
Results
The cohort-specific characteristics for the MZ twin sets are
presented in Supplementary Table S1 online. The average
age varies among the twin cohorts, being lowest in the
Netherlands (mean age 33.6 years) and highest in Sweden
(mean age 71.8 years). The MZ within-pair correlations in
our dataset for lipids and lipoproteins are presented in Ta-
ble 1. Thewithin-pair correlations vary between the cohorts
by their mean age as can be seen, for example, for the total
cholesterol measures: For the oldest cohorts, Finnish and
Swedish, the intra-pair correlations are 0.3 and 0.4, while
for the younger cohorts the correlation is around 0.6–0.7
(Table 1). For this, as well as for the known age-trend in
lipid levels, all the statistical analyses presented below are
controlled for age.
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TABLE 1
Within-Pair Correlations
Cohort HDL LDL TC TG APOA1 APOA2 APOB APOE
Australia 0.611 0.587 0.597 0.515 0.590 0.462 0.690 0.570
UK 0.670 0.688 0.687 0.657 na na na na
Sweden 0.634 0.355 0.306 0.471 0.638 na 0.418 na
Finland 0.756 0.495 0.443 0.519 0.440 0.263 0.409 na
Denmark 0.593 0.768 0.769 0.558 0.777 na 0.649 0.314
Netherlands 0.629 0.664 0.669 0.537 0.847 0.528 0.801 0.942
Combined mean 0.651 0.595 0.589 0.552 0.638 0.461 0.598 0.531
Note: The within MZ twin-pair correlations for high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL)
cholesterol, total cholesterol (TC), logarithmized triglyceride (TG), logarithmized apolipoproteins A1 (APOA1), A2
(APOA2), B (APOB), and E (APOE).
No adjustment for age was applied.
The combined means have been calculated using weights based on the size of the cohort.
na: not available.
TABLE 2
Intra-Pair Difference Association Meta-Analysis Results
Position Effect Minor allel
Phenotype SNP Chromosome Build 36 allele frequency Beta (SE) N P value Gene
HDL rs2483058 1 204693451 C 0.41 0.203 (0.037) 1,634 3.98× 10−8 SRGAP2 (intronic)
HDL rs9242 1 204704018 C 0.47 0.191 (0.036) 1,634 1.08× 10−7 SRGAP2 (untranslated)
TC rs17826288 3 109178193 G 0.38 –0.178 (0.036) 1,720 8.16× 10−7 66 kb downstream of CD47
APOA2 rs6032680 20 44215538 G 0.43 –0.394 (0.079) 696 5.82× 10−7 20 kb downstream of CDH22
Note: SNPs having P value<1×10−6 in the association analysis of inverse normal transformed absolute intra pair differences.
SE: standard error of effect estimate, beta; N: number of individuals; HDL: high-density lipoprotein; TC: total cholesterol; APOA2: apolipoprotein A2.
TABLE 3
Effects of the Genome-Wide Significant SNPs in SRGAP2 Gene in the Six Twin Cohorts
SNP Australia Beta (SE) UK Beta (SE) Sweden Beta (SE) Finland Beta (SE) Denmark Beta (SE) The Netherlands Beta(SE)
rs2483058 0.140 (0.073) 0.213 (0.078) 0.227 (0.084) 0.219 (0.133) 0.265 (0.119) 0.216 (0.094)
rs9242 0.122 (0.070) 0.226 (0.076) 0.246(0.085) 0.164 (0.135) 0.234 (0.115) 0.180 (0.089)
Note: Cohort wise results of the SNPs having P value<5×10−7 in the association analysis of inverse normal transformed absolute intra pair
differences. SE: standard error of the effect estimate, beta.
Weused the imputed genome-wide scan to identify genes
associatedwith variability of lipids and apolipoproteins (see
Figure 1). One locus having two SNPs with genome-wide
significant effect (P< 5× 10−8) on HDL variability was
found (Table 2, Figure 2) and the effects were consistent
across our six twin samples and in a joint analysis (Table 3).
The variant with stronger association is located in an intron
of the SRGAP2 gene on chromosome 1.
We tried to replicate this association in two additional
MZ twin datasets that showed positive effect for the C allele
as in the initial analysis (Table 4), but with 50% smaller
effect size. When combining results from the initial and
replication analyses, the P value did not reach genome-
wide significance (combined P value= 8.7× 10−7). In ad-
dition to twin datasets, we followed the finding in a
population cohort of 15,874 non-twin individuals with
Bartlett’s test of homogeneity of variance, but could not
find support for the finding (combined P= 0.56, data not
shown).
In addition to the one genome-wide significant hit, there
was one suggestive hit (P= 8.16× 10−7) for TC variabil-
ity, rs17826288, which is positioned 66 kb downstream of
the CD47 gene. Follow up of this locus in the population-
based cohort resulted in a combined Bartlett’s test P-value
of 0.005, but the variances increased with the G allele, while
in the MZGWA sample the variability decreases.
In addition, the aim of this study was to identify pos-
sible genes associated with apolipoprotein differences. No
genome-wide significant hits were found, but we did find
one suggestive hit associated with APOA2 intra-pair differ-
ence with a P value of 5.82× 10−7. This SNP, rs6032680,
is 20 kb downstream of CDH22 gene (Table 2). We could
not replicate this finding, as the additional twin datasets
and population-based cohort did not have measurement of
apolipoproteins.
Results from the apolipoprotein level association screen-
ing are presented in Table 5. For the APOE/APOC1 locus,
there was one SNP that had a genome-wide significant as-
sociation for APOB and APOE. In addition, we found one
new genome-wide significant locus for apolipoprotein lev-
els, DOCK1, which had an association with APOA2 levels.
There was also suggestive deviation from the expected P
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FIGURE 1
Quantile–quantile plot of all eight variability association analyses. Deviation from expected could be seen in HDL–cholesterol only.
QQ-PLOTS OF VARIABILITY ASSOCIATION ANALYSES
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FIGURE 2
(Colour online) The upper panel shows –log10 (p-values) where the black dots are imputed and gray dots genotyped SNPs. In the second
panel, the black line is the recombination rate (cM/Mb) and the red line is the distance from the best SNP measured as cM. The recom-
bination rate and genetic positions are from http://hapmap.ncbi.nlm.nih.gov/downloads/recombination/2008-03_rel22_B36/rates/.
REGIONAL ASSOCIATION PLOT OF THE SRGAP2 LOCUS
TABLE 4
Replication of rs2483058 Association on HDL-Variability in Additional Twin Datasets
Cohort Sex Effect allele Beta SE N P value
Finnish Twin cohort Male C −0.012 0.171 65 0.944
Finnish Twin cohort Female C 0.140 0.156 87 0.369
Swedish Twin Registry Male C 0.078 0.047 562 0.100
Swedish Twin Registry Female C 0.032 0.046 547 0.483
Meta C 0.098 0.032 1261 0.0020
Note: HDL-variability association results for rs2483058 in two additional monozygotic twin datasets. SE:
standard error of effect estimate, beta. N: number of individuals.
TABLE 5
Genome-Wide Significant Association Analysis Results on Apolipoprotein Levels
Position of the Effect
Locus SNP Trait Chromosome SNP Build 36 allele N Beta (SE) P value
DOCK1 rs9733352 APOA2 10 128667380 C 444 0.060 (0.011) 4.03× 10−8
APOE/APOC1 rs445925 APOB 19 50107480 G 875 0.149 (0.019) 1.65× 10−14
APOE 573 −0.229 (0.035) 4.18× 10−11
Note: SNPs having P value of lower than 5×10−8 in the association analysis of intra pair means of apolipoproteins. N: number of individuals; SE: standard
error of the effect estimate, beta; APOA2: apolipoprotein A2; APOB: apolipoprotein B; APOE= apolipoprotein E.
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values (supplementary Figure S1 online) for APOA1, but
no genome-wide significant loci were found.
Discussion
It has been shown previously (Visscher & Posthuma, 2010)
that the MZ difference approach has more power than the
population variance method when the within-pair correla-
tion of twins is higher than 0.3, which is the case for both
circulating blood lipids and apolipoproteins (Table 1). Fol-
lowing the formulae in the study by Visscher and Posthuma
(2010), with a within-pair correlation of 0.651 (0.605 for
CC homozygous pairs), which was derived from the MZ
dataset, we get a multiplicative effect of 1.17 in population
variances. For a hit with amultiplicative effect of 1.2 in vari-
ances, the relative efficiency is approximately two to three
times higher for the twin approach and the number of MZ
pairs used in this (1,720) study corresponds to a population
sample of 11,000.
Large international efforts combining results from mul-
tiple cohorts can achieve the power to detect variability of
G × E associations by increasing the number of individuals
in the analysis, but at the same time, more variability is in-
duced by population-specific effects. One of the challenges
in gene–environment interaction mapping with quantita-
tive traits is the amount of extra variability in the analysis
because of the measurement error of the environmental
factor. However, when mapping variability genes instead of
G × E interactions, this is not an issue because no specific
environmental factor is assumed.
We can infer from twin data that the differential variabil-
ity is caused by differential sensitivity to the environment
or lifestyle and not by other interacting genes, since theMZ
twins are essentially genetically identical at the sequence
level. With our genome-wide MZ twin dataset we showed
initial evidence for a locus associated with twins being dif-
ferent in their HDL values depending on their genotypes
in SRGAP2 gene. The SRGAP2 has been connected to mul-
tiple different cancers, but there is no known connection
between the gene and lipid metabolism.
Because of the restricted availability ofMZ twin datasets,
we additionally tried to replicate the genome-wide signifi-
cant finding in population based cohorts but could not find
support. This failed replication could be due to false positive
finding or power issues in homogeneity of variance analy-
sis with Bartlett’s test. The suggestive TC variability locus,
CD47, showed some evidence of variability association in
the population cohorts, but in opposite direction.
By the analysis of MZ-twin apolipoprotein levels, we
were able to replicate one previously published lipid gene,
but also found a new locus associated with APOA2. As this
is one of the first GWA analyses studying apolipoprotein
fractions in addition to lipids, further replication studies
for the new locus, DOCK1, are called for.
Themechanisms of joint actions of the gene and lifestyle
factors are unknown, but these suggestive results provide
basis for further functional and epidemiological studies.
Further, detailed consideration of environmental factors
affecting lipid levels as well as developmental changes over
the lifespan need to be incorporated in the analysis models.
Author Contributions
MP, A-CS, AP, JK, KOK, NLP, DIB, TS, NGM, SR, and LP
conceived and designed the experiments. JBW, MP, PMV,
GWM, MF, GW, EJCdG, PKEM, KC, TIAS, KHP, TR, KS,
EW, UJ, A-CS, and AP performed the experiments. IS, MP,
JM, IR, and SR analyzed the data. SR, MP, IS, NGM, PMV,
GWM, MF, PKEM, KS, EW, UL, A-CS, AP, DIB, and LP
contributed reagents/materials/analysis tools. All authors
wrote and approved the final version of the paper.
Supplementary Material is available on the Cambridge
Journals Online website.
Acknowledgments
The GenomEUtwin project is supported by the European
Commission under the program “Quality of Life andMan-
agement of the Living Resources” of 5th Framework Pro-
gramme (QLG2-CT-2002–01254).
The Swedish Twin Registry was supported by the US Na-
tional Institutes of Health (AG028555, AG08724, AG04563,
AG10175, AG08861), the Swedish Research Council, the
Swedish Heart-Lung Foundation, the Swedish Foundation
for Strategic Research, the Royal Swedish Academy of Sci-
ence, and ENGAGE (within the European Union Seventh
Framework Programme, HEALTH – F4-2007-201413).
The Danish Twin Registry has been supported by the
Danish Medical Research Council, the Danish Diabetes
Foundation, the Danish Heart Association, and the Novo
Nordic Foundation.
The TWINSUK study was funded by the Wellcome Trust
(Grant ref. 079771); European Community’s Framework
6 Project EUroClot. The study also received support from
the National Institute for Health Research (NIHR) compre-
hensive Biomedical Research Centre award to Guy’s & St
Thomas’ NHS Foundation Trust in partnership with King’s
College London. Timothy D Spector is an NIHR senior in-
vestigator and is a holder of an ERC Advanced Principal
Investigator award.
TheAustralianTwinCohortwas fundedby theAustralian
National Health and Medical Research Council (241944,
339462, 389927, 389875, 389891, 389892, 389938, 442915,
442981, 496739, 552485, 552498), the Australian Research
Council (A7960034, A79906588, A79801419, DP0770096,
DP0212016, DP0343921), and the USNational Institutes of
Health (AA07535,AA10248,AA11998,AA13320,AA13321,
AA13326, AA14041, AA17688, DA12854, MH66206).
The Netherlands Twin Registry (NTR) has been sup-
portedby theNetherlands ScientificOrganization (911–09–
032, 480–04–004, CMSB NOW Genomics, NWO–SPI 56–
464–1419, NBIC/BioAssist/RK/2008.024), BBMRI–6 NL,
TWIN RESEARCH AND HUMAN GENETICS DECEMBER 2012 697
https://doi.org/10.1017/thg.2012.63
Downloaded from https:/www.cambridge.org/core. Open University Library, on 30 Jan 2017 at 02:23:49, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Ida Surakka et al.
Institute for Health and Care Research (EMGO+), the
European Union (EU/WLRT–2001–01254, ERC Advanced
230374).
The Finnish Twin Cohort Study was supported by
the Academy of Finland Center of Excellence in Com-
plex Disease Genetics (grant numbers 213506, 129680),
the Finnish Foundation for Cardiovascular Research, the
Finnish Academy (grant numbers 129494, 139635, and
251217), and the Sigrid Juselius Foundation.
Platform in Uppsala is funded by Uppsala University and
Uppsala University Hospital and the Swedish Wallenberg
Foundation.
SR was supported by the Academy of Finland Center
of Excellence in Complex Disease Genetics (213506 and
129680), Academy of Finland (251217), the Finnish foun-
dation for Cardiovascular Research, and the Sigrid Juselius
Foundation.MP ispartlyfinancially supported for thiswork
by the Finnish Academy SALVE program “Pubgensense”
129322 and by grants from Finnish Foundation for Car-
diovascular Research. KP was funded by Helsinki Univer-
sity Central Hospital grants. TR has been funded from
the Academy of Finland Research Programme on Ageing,
Finnish Ministry of Education.
We thank the staff of the SNP Platform for their contri-
butions to genotyping.
References
Aulchenko, Y. S., Ripatti, S., Lindqvist, I., Boomsma, D., Heid,
I. M., Pramstaller, P. P., Penninx, B. W., Janssens, A. C.,
Wilson, J. F., Spector, T., Martin, N. G., Pedersen, N. L.,
Kyvik, K.O., Kaprio, J.,Hofman,A., Freimer,N. B., Jarvelin,
M. R., Gyllensten, U., Campbell, H., Rudan, I., Johansson,
A.,Marroni, F.,Hayward,C., Vitart, V., Jonasson, I., Pattaro,
C.,Wright, A.,Hastie,N., Pichler, I.,Hicks, A.A., Falchi,M.,
Willemsen, G., Hottenga, J. J., de Geus, E. J., Montgomery,
G. W., Whitfield, J., Magnusson, P., Saharinen, J., Perola,
M., Silander, K., Isaacs, A., Sijbrands, E. J., Uitterlinden,
A. G., Witteman, J. C., Oostra, B. A., Elliott, P., Ruokonen,
A., Sabatti, C., Gieger, C., Meitinger, T., Kronenberg, F.,
Do¨ring, A., Wichmann, H. E., Smit, J. H., McCarthy, M. I.,
van Duijn, C. M., Peltonen, L., & ENGAGE Consortium.
(2008). Loci influencing lipid levels and coronary heart
disease risk in 16 European population cohorts. Nature
Genetics, 41, 47–55.
Beekman, M., Heijmans, B. T., Martin, N. G., Pedersen, N. L.,
Whitfield, J. B., DeFaire, U., van Baal, G. C., Snieder, H.,
Vogler, G. P., Slagboom, P. E., & Boomsma, D. I. (2002).
Heritabilities of apolipoprotein and lipid levels in three
countries. Twin Research, 5, 87–97.
Broms, U., Wedenoja, J., Largeau, M. R., Korhonen, T.,
Pitka¨niemi, J., Keskitalo-Vuokko, K., Ha¨ppo¨la¨, A., Heikkila¨,
K. H., Heikkila¨, K., Ripatti, S., Sarin, A. P., Salminen, A. P.,
Paunio, T., Pergadia, M. L., Madden, P. A., Kaprio, J., &
Loukola, A. (2012). Analysis of detailed phenotype profiles
reveals CHRNA5-CHRNA3-CHRNB4 gene cluster associ-
ation with several nicotine dependence traits. Nicotine &
Tobacco Research, 14, 720–733.
Friedlander, Y., Austin, M. A., Newman, B., Edwards, K.,
Mayer-Davis, E. I., & King, M. C. (1997). Heritability of
longitudinal changes in coronary-heart-disease risk factors
in women twins. American Journal of Human Genetics, 60,
1502–1512.
Hannelius, U., Gherman, L., Ma¨kela¨, V. V., Lindstedt, A., Zuc-
chelli, M., Lagerberg, C., Tybring, G., Kere, J., & Lindgren,
C. M. (2007). Large-scale zygosity testing using single nu-
cleotide polymorphisms. Twin Research and Human Genet-
ics, 10, 604–625.
Howie, B.N.,Donnelly, P., &Marchini, J. (2009). A flexible and
accurate genotype imputation method for the next genera-
tion of genome-wide association studies. PLoS Genetics, 5,
e1000529.
Kannel, W. B., Kagan, A., Revotskie, N., & Stokes, J. I.
(1961). Factors of risk in the development of coro-
nary heart disease–six year follow-up experience. The
Framingham Study. Annals of Internal Medicine, 55,
33–50.
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt,
N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F.,
Havulinna,A. S.,Wahlstrand,B.,Hedner,T.,Corella,D.,Tai,
E. S., Ordovas, J.M., Berglund,G., Vartiainen, E., Jousilahti,
P., Hedblad, B., Taskinen, M. R., Newton-Cheh, C., Salo-
maa, V., Peltonen, L., Groop, L., Altshuler, D. M., & Orho-
Melander, M. (2008). Six new loci associated with blood
low-density lipoprotein cholesterol, high-density lipopro-
tein cholesterol or triglycerides in humans.Nature Genetics,
40, 189–197.
Kooner, J. S., Chambers, J. C., Aguilar-Salinas, C. A., Hinds,
D. A., Hyde, C. L., Warnes, G. R., Gomez Perez, F. J., Frazer,
K. A., Elliott, P., Scott, J., Milos, P. M., Cox, D. R., &
Thompson, J. F. (2008). Genome-wide scan identifies vari-
ation in MLXIPL associated with plasma triglycerides.
Nature Genetics, 40, 149–151.
Loukola, A., Broms, U., Maunu, H., Wide´n, E., Heikkila¨, K.,
Siivola, M., Salo, A., Pergadia, M. L., Nyman, E., Sammal-
isto, S., Perola, M., Agrawal, A., Heath, A. C., Martin, N. G.,
Madden, P. A., Peltonen, L., & Kaprio, J. (2008). Linkage
of nicotine dependece and smoking behavior on 10q, 7q
and 11p in twins with homogeneus genetic background.
Pharmacogenomics Journal, 8, 209–219.
Magnus, P., Berg, K., Borreson, A. L., & Nance, W. E. (1981).
Apparent influence of marker genotypes on variation in
serum cholesterol inmonozygotic twins. Clinical Genetics,
19, 67–70.
Marchini, J., Howie, B. N., Myers, S., McVean, G., & Donnelly,
P. (2007). A newmultipointmethod for genome-wide asso-
ciation studies by imputationof genotypes.NatureGenetics,
39, 906–913.
Miller, N. E., & Miller, M. G. (1975). Letter to the Editor:
High-density lipoprotein and atherosclerosis. Lancet, 305,
1033.
Nyholt, D. R. (2006). On the probability of dizygotic twins
being concordant for two alleles at multiple polymorphic
loci. Twin Research and Human Genetics, 9, 194–197.
Peltonen, L., & GenomEUtwin project. (2003). A Strategy to
Identify Genetic Influences on Health and Disease. Twin
Research, 6, 354–360.
698 DECEMBER 2012 TWIN RESEARCH AND HUMAN GENETICS
https://doi.org/10.1017/thg.2012.63
Downloaded from https:/www.cambridge.org/core. Open University Library, on 30 Jan 2017 at 02:23:49, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
A Genome-Wide Screen For Lipid Variability
Pilia, G., Chen, W. M., Scuteri, A., Orru, M., Albai, G., Dei,
M., Lai, S., Usala, G., Lai, M., Loi, P., Mameli, C., Vacca,
L., Deiana, M., Olla, N., Masala, M., Cao, A., Najjar, S.
S., Terracciano, A., Nedorezov, T., Sharov, A., Zonderman,
A. B., Abecasis, G. R., Costa, P., Lakatta, E., & Schlessinger,
D. (2006). Heritability of cardiovascular and personality
traits in 6,148 Sardinians. PLoS Genetics, 2, e132.
Steemers, F. J., Chang, W., Lee, G., Barker, D. L., Shen, R., &
Gunderson, K. L. (2006). Whole-genome genotyping with
the single-base extension assay. Nature Methods, 3, 31–33.
Surakka, I., Isaacs, A., Karssen, L., Laurila, P.-P., Middelberg,
R., Tikkanen, E., Ried, J., Lamina, C., Mangino, M., Igl,
W., Hottenga, J., Lagou, V., van der Harst, P., Mateo Leach,
I., Esko, T., Kutalik, Z., Wainwright, N., Struchalin, M.,
Sarin, A.-P., Kangas, A., Viikari, J., Perola, M., Rantanen,
T., Petersen, A.-K., Soininen, P., Johansson, A˚., Soranzo,
N., Heath, A., Papamarkou, T., Prokopenko, I., To¨njes, A.,
Kronenberg, F., Do¨ring, A., Rivadeneira, F., Montgomery,
G., Whitfield, J., Ka¨ho¨nen, M., Lehtima¨ki, T., Freimer, N.,
Willemsen, G., de Geus, E., Palotie, A., sandhu, M., Wa-
terworth, D., Metspalu, A., Stumwoll, M., Uitterlinden, A.,
Jula, A., Navis, G., Wijmenga, C., Wolffenbuttel, B., Taski-
nen, M., Ala-Korpela, M., Kaprio, J., Kyvik, K., Boomsma,
D., Pedersen, N., Gyllensten, U., Wilson, J., Rudan, I.,
Campbell, H., Pramstaller, P., Spector, T., Witteman, J.,
Eriksson, J., Salomaa, V., Oostra, B., Raitakari, O., Wich-
mann, H., Gieger, C., Ja¨rvelin, M.-R., Martin, N., Hofman,
A., McCarthy, M., Peltonen, L., Van Duijn, C., Aulchenko,
Y., Ripatti, S., & ENGAGE Consortium (2011). A genome-
wide screen for interactions reveals a new locus on 4p15
modifying the effect of waist-to-hip ratio on total choles-
terol. PLoS Genetics, 7, e1002333.
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson,
A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti,
S., Chasman, D. I., Willer, C. J., Johansen, C. T., Fouchier,
S. W., Isaacs, A., Peloso, G. M., Barbalic, M., Ricketts, S. L.,
Bis, J. C., Aulchenko, Y. S., Thorleifsson, G., Feitosa, M. F.,
Chambers, J., Orho-Melander, M., Melander, O., Johnson,
T., Li, X., Guo, X., Li, M., Shin Cho, Y., Jin Go, M., Jin Kim,
Y., Lee, J. Y., Park, T., Kim, K., Sim, X., Twee-Hee Ong, R.,
Croteau-Chonka, D. C., Lange, L. A., Smith, J. D., Song, K.,
Hua Zhao, J., Yuan, X., Luan, J., Lamina, C., Ziegler, A.,
Zhang, W., Zee, R. Y., Wright, A. F., Witteman, J. C., Wil-
son, J. F., Willemsen, G., Wichmann, H. E., Whitfield, J. B.,
Waterworth, D. M., Wareham, N. J., Waeber, G., Vollen-
weider, P., Voight, B. F., Vitart, V., Uitterlinden, A. G., Uda,
M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I.,
Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H.,
Sinisalo, J., Silander, K., Sijbrands, E. J., Scuteri, A., Scott,
J., Schlessinger, D., Sanna, S., Salomaa, V., Saharinen, J.,
Sabatti, C., Ruokonen, A., Rudan, I., Rose, L. M., Roberts,
R., Rieder,M., Psaty, B.M., Pramstaller, P. P., Pichler, I., Per-
ola, M., Penninx, B. W., Pedersen, N. L., Pattaro, C., Parker,
A. N., Pare, G., Oostra, B. A., O’Donnell, C. J., Nieminen,
M. S., Nickerson, D. A., Montgomery, G. W., Meitinger, T.,
McPherson, R., McCarthy, M. I., McArdle, W., Masson, D.,
Martin, N. G., Marroni, F., Mangino, M., Magnusson, P.
K., Lucas, G., Luben, R., Loos, R. J., Lokki, M. L., Lettre,
G., Langenberg, C., Launer, L. J., Lakatta, E. G., Laakso-
nen, R., Kyvik, K. O., Kronenberg, F., Ko¨nig, I. R., Khaw,
K. T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M.
R., Janssens, A. C., Ingelsson, E., Igl, W., Kees Hovingh,
G., Hottenga, J. J., Hofman, A., Hicks, A. A., Hengstenberg,
C., Heid, I. M., Hayward, C., Havulinna, A. S., Hastie, N.
D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten,
U., Guiducci, C., Groop, L. C., Gonzalez, E., Gieger, C.,
Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe,
K. G., Do¨ring, A., Dominiczak, A. F., Demissie, S., De-
loukas, P., de Geus, E. J., de Faire, U., Crawford, G., Collins,
F. S., Chen, Y. D., Caulfield, M. J., Campbell, H., Burtt, N.
P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M.,
Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C.
M., Assimes, T. L., Quertermous, T., Altshuler, D., Seielstad,
M., Wong, T. Y., Tai, E. S., Feranil, A. B., Kuzawa, C. W.,
Adair, L. S., Taylor, H. A. Jr, Borecki, I. B., Gabriel, S. B.,
Wilson, J. G., Holm,H., Thorsteinsdottir, U., Gudnason, V.,
Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B.,
Kooner, J. S., Tall, A. R.,Hegele, R. A., Kastelein, J. J., Schadt,
E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser,
V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert,
H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D.
J., van Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke,
M., & Kathiresan, S. (2010). Biological, clinical and pop-
ulation relevance of 95 loci for blood lipids. Nature, 466,
707–713.
Thorn, J. A.,Needham, E.W.,Mattu, R.K., Stocks, J., &Galton,
D. J. (1998). The Ser447-Ter mutation of the lipoprotein li-
pase gene relates to variability of serumlipid and lipoprotein
levels in monozygotic twins. Journal of Lipid Research, 39,
437–441.
Visscher, P. M., & Duffy, D. L. (2006). The value of relatives
with phenotypes butmissing genotypes in association stud-
ies for quantitative traits. Genetic Epidemiology, 30, 30–36.
Visscher, P., & Posthuma, D. (2010). Statistical power to de-
tect genetic Loci affecting environmental sensitivity. Be-
havioural Genetics, 40, 728–733.
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle,
L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S.,
Stringham, H. M., Strait, J., Duren, W. L., Maschio, A., Bu-
sonero, F., Mulas, A., Albai, G., Swift, A. J., Morken, M. A.,
Narisu,N., Bennett,D., Parish, S., Shen,H.,Galan, P.,Mene-
ton, P., Hercberg, S., Zelenika, D., Chen,W.M., Li, Y., Scott,
L. J., Scheet, P. A., Sundvall, J., Watanabe, R. M., Nagaraja,
R., Ebrahim, S., Lawlor, D. A., Ben-Shlomo, Y., Davey-
Smith, G., Shuldiner, A. R., Collins, R., Bergman, R.N.,
Uda, M., Tuomilehto, J., Cao, A., Collins, F. S., Lakatta,
E., Lathrop, G. M., Boehnke, M., Schlessinger, D., Mohlke,
K. L., & Abecasis, G. R. (2008). Newly identified loci that
influence lipid concentrations and risk of coronary artery
disease. Nature Genetics, 40, 161–169.
TWIN RESEARCH AND HUMAN GENETICS DECEMBER 2012 699
https://doi.org/10.1017/thg.2012.63
Downloaded from https:/www.cambridge.org/core. Open University Library, on 30 Jan 2017 at 02:23:49, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
